Breaking News

A leprosy expert calms your fears

August 27, 2023
Editor, First Opinion

I really should have known that leprosy doesn't make your nose fall off.

When I think about it, it makes absolute sense. But somehow, I believed that damaging myth until I edited Andrea Maderal's First Opinion, published this week, on the new panic over leprosy, also known as Hansen's disease.

Earlier this month, Emerging Infectious Diseases published a research letter warning that leprosy may have become endemic in Florida. The report led to panicked headlines (and not a few crass jokes). But I wanted to know more. One of the many privileges of being the editor of First Opinion is that when I have a question about something in medicine, biotech, or an associated field, I have a great excuse to reach out to the smartest thinkers on that topic. I quickly discovered that the person I absolutely needed to speak to about leprosy was Maderal, the director for the University of Miami/Jackson Memorial Hospital Hansen's Disease Clinic — that's right, a leprosy expert right in the heart of Florida.

Maderal confessed to being a little surprised about the hubbub the report had generated. But she agreed to write a First Opinion offering an expert's-eye view of the news. "As a physician in Florida who specializes in treating leprosy, also known as Hansen's disease, this case report was not 'news' to us in the field: We have known for some time about endemic cases of leprosy. However, given how rare the disease is in the state, there is no cause for alarm — despite the fearful headline," she says. What follows is a must-read that busts myths (see: my embarrassing belief about noses), educates, and calms fears.

Also in First Opinion this week: In an excerpt from his fascinating new book "How to Make a Killing: Blood, Death and Dollars in American Medicine" (what a title, right?), Tom Mueller writes about the very human-centric approach to dialysis in Australia. Dana Singiser explains how to make over-the-counter birth control affordable for all who need it. We have two important pieces on hospice: one on why the industry owes Americans an apology, and one on how to make it work for trans people. And so much more.

Got an idea for First Opinion? Thoughts on what we should do differently or better? Email me.

Micrograph of lepromatous leprosy.
Wikimedia Commons

I'm a doctor who specializes in treating leprosy. Here's what I want you to know

As a doctor in Florida who treats leprosy, I'm glad to see people paying attention to the disease. But the fear is outsized.

By Andrea Maderal


Surfing, camping, and deciding when to stop: Australia's human-centric approach to dialysis

This excerpt from Tom Mueller's "How to Make a Killing" shows Australia and America have traveled very different paths in dialysis.

By Tom Mueller


Current large language models will not fix health care. Here's what could

Simply augmenting existing foundation AI models with health care data misses a much bigger opportunity.

By Jenna Wiens and Rada Mihalcea and Brahmajee K. Nallamothu



Adobe

A roadmap for making over-the-counter birth control affordable

Allowing people to get over-the-counter birth control is a monumental win. Now we need to make sure everyone can afford it.

By Dana Singiser


How to save the U.S. News & World Report Best Hospitals rankings

Now is the time for health care ratings to offer patients transparent and useful measures of quality that enable informed choices.

By Brian Stein and Bala Hota


How to take care of trans patients in hospice

Trans patients' end-of-life journey poses unique challenges, many of which are rooted in fear of being judged, humiliated, and excluded.

By Dallas Ducar and Cathy Campbell


John Moore/Getty Images

The hospice industry needs major reforms. It should start with apologies

If you spend time with dying patients and their families, you learn about the value of apologies. Hospice should take note.

By Ira Byock


What the hospital-at-home movement tells us about igniting innovation in health care

Hospital-at-home programs have been studied since the 1970s. But it took a pandemic to jump-start them. It shouldn't have been that way.

By James B. Rebitzer and Robert S. Rebitzer


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying First Opinion? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments